Barry A. Gusterson - Concepedia

Author

Barry A. Gusterson

Also Known As

B A Gusterson, B Gusterson, BARRY A. GUSTERSON, Barry A Gusterson, Barry A. GUSTERSON, Barry A. Gusterson, Barry Gusterson, Barry A. Gusterson, Gusterson, Barry, On the behalf of the International Breast Cancer Study Group

152

Publications

22.8K

Citations

H-Index

103

Concepts

All Affiliations

Institute of Cancer Research University of Glasgow Western Infirmary Royal Marsden NHS Foundation Trust Royal Marsden Hospital

About

Barry A. Gusterson is an author at Institute of Cancer Research specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	49	15.1K
2	Health Sciences	5	5	301
3	Natural Sciences	2	2	49
4	Public Health	2	2	596
5	Biochemistry	1	1	13

Barry A. Gusterson

Publications

20.2K

Citations

H-Index

Page 1

	Year	Citations
Mutations of the BRAF gene in human cancer Helen Davies, Graham R. Bignell, Charles Cox, Nature Somatic VariantBraf GeneGeneticsCancer GenomicsCancer Genetics	2002	10.6K
Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma Jeremy Clark, Philippe J. Rocques, A. Jayne Crew, Nature Genetics Novel GenesImmunologyPathologyHuman Synovial SarcomaAdult T-cell Leukemia-lymphoma	1994	757
Prediction of <i>BRCA1</i> Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype Sunil R. Lakhani, Jorge S. Reis‐Filho, Laura Fulford, Clinical Cancer Research	2005	605
Comparative Study of Human and Rat Mammary Tumorigenesis José Russo, Barry A. Gusterson, Adrianne E. Rogers, Humana Press eBooks InfertilityBreast OncologyFertilityReproductive HealthMammary Gland	1990	583
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour María C. Marín, Christine A. Jost, Louise Brooks, Nature Genetics Intragenic ModifierSomatic VariantGenetic DisorderGeneticsHuman Polymorphism	2000	519
Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon, Journal of Clinical Oncology	2008	484
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis Daniele Bergamaschi, Milena Gasco, Louise Hiller, Cancer Cell Tumor BiologyOncologyMedicineApoptosisCell Death	2003	456
Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98 Giuseppe Viale, Meredith M. Regan, Eugenio Maiorano, Journal of Clinical Oncology	2007	452
Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3 Torsten Stein, Joanna S. Morris, Claire Davies, Breast Cancer Research	2003	377
Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole Giuseppe Viale, Anita Giobbie‐Hurder, Meredith M. Regan, Journal of Clinical Oncology	2008	340

Page 1